• Publications
  • Influence
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
BACKGROUND Myocarditis is an uncommon, but potentially fatal, toxicity of immune checkpoint inhibitors (ICI). Myocarditis after ICI has not been well characterized. OBJECTIVES The authors sought toExpand
  • 371
  • 21
A comparison of non-integrating reprogramming methods
TLDR
We compare Sendai-viral (SeV), episomal (Epi) and mRNA transfection mRNA methods for generating integration-free hiPSCs using a number of criteria. Expand
  • 300
  • 18
Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer.
PURPOSE Cardiovascular disease (CVD) is a leading cause of death among women with nonmetastatic breast cancer. Whether exercise is associated with reductions in CVD risk in patients with breastExpand
  • 80
  • 4
Exercise Therapy and Cardiovascular Toxicity in Cancer
Cardio-oncology is an emerging discipline focused predominantly on the detection and management of cancer treatment–induced cardiac dysfunction (cardiotoxicity), which predisposes to development ofExpand
  • 71
  • 3
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis.
AIMS Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data exist on the use of cardiovascular magnetic resonance (CMR) in ICI-associated myocarditis. InExpand
  • 29
  • 3
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
BackgroundInfluenza vaccination (FV) is recommended for patients with cancer. Recent data suggested that the administration of the FV was associated with an increase in immune-related adverse eventsExpand
  • 29
  • 2
  • PDF
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis.
Importance Echocardiographic left ventricular global longitudinal strain (GLS) detects early subclinical ventricular dysfunction and can be used in patients receiving potentially cardiotoxicExpand
  • 29
  • 2
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis.
BACKGROUND There is a need for improved methods for detection and risk stratification of myocarditis associated with immune checkpoint inhibitors (ICIs). Global longitudinal strain (GLS) is aExpand
  • 27
  • 2
p-Hydroxy acetophenone derivatives from Dioscorea bulbifera
Abstract From the bulbs of Dioscorea bulbifera , two new p -hydroxy acetophenone derivatives, namely 4-hydroxy-[2- trans -3′,7′-dimethyl-octa-2′,6′-dienyl]-6-methoxyacetophenone and 4,6-dihydroxy-2-Expand
  • 13
  • 2
Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training.
OBJECTIVE Background parenchymal enhancement (BPE) refers to enhancing fibroglandular tissue on initial contrast-enhanced MR images. BPE appears to impact the rate of abnormal MRI interpretation andExpand
  • 34
  • 1
...
1
2
3
4
5
...